Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00126802
Status:
UNKNOWN
Last Update Posted:
2016-07-06
First Post:
2005-08-03
Brief Title:
The Role of Tomotherapy in HypofractionatedDose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer
Sponsor:
AHS Cancer Control Alberta
Organization:
AHS Cancer Control Alberta
Study Overview
Official Title:
The Role of Tomotherapy Dynamic IMRT and Megavoltage CT Scanning in HypofractionatedDose Escalated Conformal Radiation Treatment Using Magnetic Resonance Spectroscopy MRS Scans to Predict and Document the Pattern of Local Failure for High Risk Prostate Cancer
Status:
UNKNOWN
Status Verified Date:
2016-07
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Helical tomotherapy is being used to treat the prostate gland local rates of spread and regional lymph nodes whilst sparing gross structures The radiation to the gross disease in the prostate is hypofractionated and dose escalated Magnetic resonance spectroscopic imaging MRSI is incorporated into pre- and post-treatment evaluation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None